Yes, butalbital is a Schedule III controlled substance under federal law. It is classified as a barbiturate, a derivative of barbituric acid, and falls under DEA Controlled Substances Code Number 2100. However, the answer gets more complicated depending on which butalbital product you’re prescribed, because certain combination formulations have historically been treated differently than the pure drug.
Federal Scheduling: Schedule III
Butalbital on its own is firmly a Schedule III controlled substance. Schedule III means the drug has a moderate-to-low potential for physical and psychological dependence, placing it in the same category as testosterone, ketamine, and certain codeine combinations. This classification applies to butalbital as a standalone ingredient and to any product that doesn’t qualify for a specific federal exemption.
What makes butalbital’s legal status confusing is that the two most well-known brand-name products containing it, Fiorinal and Fioricet, have historically been regulated very differently despite containing the same amount of butalbital (50 mg per dose).
Why Fiorinal and Fioricet Were Treated Differently
Fiorinal combines butalbital with aspirin and caffeine. Fioricet combines butalbital with acetaminophen and caffeine. Since 1967, Fiorinal has been regulated as a full Schedule III controlled substance, while Fioricet was granted “exempted prescription product” status, meaning it could be prescribed and refilled more like a standard (non-controlled) medication in many contexts.
The reasoning behind this split came down to a specific formula. Federal rules allowed an exemption for barbiturate combinations if the other ingredients were present in quantities large enough to deter abuse through unpleasant side effects. For every 15 mg of barbiturate, the product needed at least 70 mg of acetaminophen. Fioricet met that ratio: its 50 mg of butalbital was paired with 300 mg of acetaminophen, and the logic was that anyone trying to take enough capsules to get high from the butalbital would risk serious liver damage from the acetaminophen. Fiorinal’s aspirin, on the other hand, didn’t meet its own required ratio of 188 mg per 15 mg of barbiturate, so it never qualified for exemption.
This created a practical oddity. Two medications with the same active controlled ingredient were handled under completely different rules at the pharmacy counter.
The DEA’s Shift on Exempted Products
The DEA has since acknowledged that acetaminophen hasn’t actually deterred abuse of butalbital combination products the way regulators expected. The agency documented a clear pattern of diversion, online distribution, and abuse of exempted butalbital products, and specifically noted that people exploited the exempted status to obtain butalbital more easily. In a 2022 Federal Register notice, the DEA concluded that these products no longer meet the legal criteria for exemption because the acetaminophen simply hasn’t reduced their abuse potential.
As of April 2026, multiple butalbital-acetaminophen-caffeine formulations still appear on the DEA’s Table of Exempted Prescription Products, but the regulatory landscape around these products is actively shifting. Some states have already moved to classify all butalbital products as controlled substances regardless of what the federal exemption list says. If you’re unsure how your state handles your specific prescription, your pharmacist can tell you exactly how it’s regulated where you live.
What Butalbital Does in Your Body
Butalbital is a barbiturate that depresses the central nervous system. It works by altering activity in the parts of the brain responsible for sensory processing, coordination, and motor function. This produces muscle relaxation and sedation, which is why it’s prescribed for tension-type headaches where muscle tightness in the head and neck contributes to pain. The standard dose is one or two capsules every four hours as needed, with a maximum of six capsules per day.
The drug is absorbed quickly through the digestive tract and spreads widely through body tissues. Its half-life is about 35 hours, meaning it takes roughly a day and a half for your body to clear just half of a single dose. That long half-life matters because butalbital can accumulate in your system if you’re taking it frequently, which increases both sedation and the risk of dependence.
Dependence and Withdrawal Risk
Butalbital can become habit-forming with regular use, leading to both mental and physical dependence. This is true of barbiturates as a class, and it’s the core reason butalbital carries a controlled substance classification. Physical dependence means your body adjusts to the drug’s presence and reacts when it’s removed.
If you’ve been taking butalbital regularly for weeks or longer, stopping abruptly can trigger withdrawal symptoms. Barbiturate withdrawal is potentially serious, more so than withdrawal from many other drug classes. Symptoms can include anxiety, tremors, insomnia, nausea, and in severe cases, seizures. Tapering the dose gradually under medical guidance prevents most severe withdrawal effects. This is not a medication you should stop cold turkey if you’ve been using it consistently.
How Controlled Status Affects Your Prescription
For butalbital products regulated as Schedule III (like Fiorinal and its generics), federal rules allow a maximum of five refills within six months of the original prescription date. After that, you need a new prescription. These products also require more detailed record-keeping at the pharmacy level and can’t be called in as freely in some states.
For butalbital products that still carry exempted status in your state (like some Fioricet generics), the prescription process may feel identical to picking up any other non-controlled medication. You may get more refills and face fewer restrictions at the pharmacy. But this doesn’t change the pharmacology of the drug itself. The butalbital in an exempted product carries the same dependence risk and the same sedating effects as the butalbital in a fully scheduled one. The legal distinction is about regulatory convenience, not safety.